Insider Trading & Ownership of James Hassard

Location
Pasadena, CA
Summary
The estimated net worth of James Hassard is at least $5,241,615 dollars as of 09 Jul 2024. James Hassard is the Chief Commercial Officer of ARROWHEAD PHARMACEUTICALS, INC. and owns shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR) stock worth about $3.95M. James Hassard is the Chief Commercial Officer of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $1.29M.
Signature
Marc Wilson, as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow James Hassard and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • James Hassard has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,241,615.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ARROWHEAD PHARMACEUTICALS, INC. ($3,951,878).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of James Hassard

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARWR ARROWHEAD PHARMACEUTICALS, INC. Chief Commercial Officer $3,951,878 22 Jun 2021
CRNX Crinetics Pharmaceuticals, Inc. Chief Commercial Officer $1,289,737 05 Jul 2024

Insider Transactions Reported by James Hassard:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .